- Home
- RBOT vs AVTX Comparison
RBOT vs AVTX Comparison
Compare RBOT & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBOT
- AVTX
- Stock Information
- Founded
- RBOT 2014
- AVTX 2011
- Country
- RBOT United States
- AVTX United States
- Employees
- RBOT N/A
- AVTX N/A
- Industry
- RBOT Medical Specialities
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- RBOT Health Care
- AVTX Health Care
- Exchange
- RBOT Nasdaq
- AVTX Nasdaq
- Market Cap
- RBOT 65.0M
- AVTX 88.4M
- IPO Year
- RBOT N/A
- AVTX 2015
- Fundamental
- Price
- RBOT $9.11
- AVTX $7.99
- Analyst Decision
- RBOT Hold
- AVTX Strong Buy
- Analyst Count
- RBOT 2
- AVTX 5
- Target Price
- RBOT $10.25
- AVTX $36.75
- AVG Volume (30 Days)
- RBOT 50.5K
- AVTX 98.4K
- Earning Date
- RBOT 04-28-2025
- AVTX 03-28-2025
- Dividend Yield
- RBOT N/A
- AVTX N/A
- EPS Growth
- RBOT N/A
- AVTX N/A
- EPS
- RBOT N/A
- AVTX N/A
- Revenue
- RBOT N/A
- AVTX $820,000.00
- Revenue This Year
- RBOT N/A
- AVTX N/A
- Revenue Next Year
- RBOT N/A
- AVTX N/A
- P/E Ratio
- RBOT N/A
- AVTX N/A
- Revenue Growth
- RBOT N/A
- AVTX N/A
- 52 Week Low
- RBOT $4.27
- AVTX $4.35
- 52 Week High
- RBOT $19.00
- AVTX $34.46
- Technical
- Relative Strength Index (RSI)
- RBOT 34.99
- AVTX 54.79
- Support Level
- RBOT $8.34
- AVTX $6.38
- Resistance Level
- RBOT $10.70
- AVTX $8.90
- Average True Range (ATR)
- RBOT 1.12
- AVTX 1.13
- MACD
- RBOT -0.39
- AVTX 0.08
- Stochastic Oscillator
- RBOT 10.24
- AVTX 33.61
About RBOT Vicarious Surgical Inc.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).